Some of our cancer centers are experiencing issues.  View More Important Notifications x
texas oncology more breakthroughs. more victories



Habte Yimer, MD, Speculates on the Future of Anti-BCMA CAR-T Cell Therapy

Publication: Oncology Business Review

Habte Yimer, hematologist and medical oncologist with Texas Oncology–Tyler, shares thoughts on whether anti-BCMA CAR-T cell therapy looks promising as a treatment option for multiple myeloma patients.
Click here to watch the full story.

Related Physicians

Related Cancer Centers